INCREASED plasma-and tissue levels of endothelin-1 (ET-1) during 
Introduction
Endothelin-1 (ET-1) was originally described as a potent vasoactive peptide released from endothelial cells. 1 '2 The observation that macrophages and mast cells both release and have receptors for ET-1, has suggested that ET-1 possibly plays a role as a modulator of monocyte/macrophage function. 3, 4 Increased plasma-and tissue levels of ET-1 are reported in patients with inflammatory diseases such as rheumatoid arthritis, Mb.Crohn and septic shock. 5 For comparison, Table 1 shows the response to LPS 0.1/g/ml. After 24h, LPS stimulation caused a strong five-to ten-fold increase in release of TNF-0, IL-lfl and IL-6 from monocytes and macrophages.
Kinetics of ET-1 induced TNF-o release from monocytes and macrophages: As shown in Fig. 2A , the time-course study revealed that ET-1 stimulation had increased monocyte TNF-production after 1 h incubation. In the macrophage culture supernatants, ET-1 had increased TNF-0 production three-fold by 1 h; whereas by 4h and 8 h the TNF-level had returned to baseline. By 24 h the TNF-level had increased by 250%.
Kinetics of ET-l-induced IL-6 release from monocytes and macrophages: As shown in Fig. 2B , ET-1 increased monocyte IL-6 production slightly after 4h stimulation, and levels were still elevated at 24 h.
In the macrophage cultures ET-1 had induced IL-6 production by 1 h, reaching a two-fold peak concentration in the supernatants within 4 h, and declining, but still increased as compared with controls, by 24 h.
Kinetics of ET-l-induced IL-1 release from monocytes and macrophages: As shown in Fig. 2C , ET-1 increased monocyte IL-lfl production, as measured in the supernatants, after 8 h, reaching more than a two-fold increase by 24 h. In macrophage supernatants increased IL-lfl levels were detected by 4 Fig. 3 .
